Zeta Navigation System Gains FDA Clearance for Brain Tumor Biopsy and Neurosurgery
FDA & EMA
SUNRISE-II Trial Begins Evaluating Ultrasound-Guided HIFU Ablation for Pancreatic Cancer
Clinical Trials
FDA-Cleared Utepreva Device Aims to Improve Early Endometrial Cancer Detection
Cancer
FDA Approves Breakthrough Device: Altius System to Tackle Chronic Amputation Pain
Medical Devices
Monteris Introduces Smallest NB3 Laser Probe for Brain Tumor Surgery
BioTrace: First FDA-Cleared Ultrasound Software for Liver Tumor Response Prediction
World's First Chronic Migraine Therapy System Successfully Implanted in Six Patients
Medtronic's PulseSelect PFA System Earns FDA Approval for Atrial Fibrillation Treatment
BD Launches Vascular Access Ultrasound System to Enhance Clinician Efficiency
How Soft Supercapacitors Could Transform the Future of Implantable Medical Devices?
Subscribe for the latest news and events
Most Popular
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma
